Hawley, Sarah T. http://orcid.org/0000-0001-5756-645X
Kidwell, Kelley
Zahrieh, David
McCarthy, Anne
Wills, Rachel
Rankin, Aaron
Hofer, Timothy
Chow, Selina
Jagsi, Reshma
Neuman, Heather
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (CA237046))
Article History
Received: 13 October 2022
Accepted: 21 December 2022
First Online: 6 January 2023
Declarations
:
: This study obtained approval from the NCI Central IRB. Written, informed consent to participate will be obtained from all participants.
: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. Informed consent materials are attached as supplementary materials.
: DZ is currently an employee at Utralgenyx Pharmaceutical Inc. This work is not sponsored by Ultragenyx. At the time of this research and protocol development, DZ was an employee of Mayo Clinic and the Alliance Statistics and Data Center. RJ has stock options as compensation for her advisory board role in Equity Quotient, a company that evaluates culture in health care comparisons; she has received personal fees for the National Institutes of Health (in her role as a member of the Advisory Committee for Research on Women’s’ Health and the Board of Scientific Counselors), the Greenwall Foundation, and the Doris Duke Charitable Foundation. RJ has a contract to conduct an investigator-initiated study with Genentech. She has served as an expert witness for Sherinian and Hasso, Dressman Benziger LaVelle, and Klieinbard LLC. The other authors declare that they have no competing interests.